Cite
Analyses of Basal and Squamous Cell Carcinoma Reported as an Adverse Drug Reaction and Comparison with Cases from the Cancer Registry from Germany.
MLA
Dubrall, Diana, et al. “Analyses of Basal and Squamous Cell Carcinoma Reported as an Adverse Drug Reaction and Comparison with Cases from the Cancer Registry from Germany.” Drugs in R&D, vol. 23, no. 1, Mar. 2023, pp. 21–33. EBSCOhost, https://doi.org/10.1007/s40268-022-00407-1.
APA
Dubrall, D., Sachs, B., Kraywinkel, K., Schulz, M., Schmid, M., Fischer-Barth, W., & Bate, J. (2023). Analyses of Basal and Squamous Cell Carcinoma Reported as an Adverse Drug Reaction and Comparison with Cases from the Cancer Registry from Germany. Drugs in R&D, 23(1), 21–33. https://doi.org/10.1007/s40268-022-00407-1
Chicago
Dubrall, Diana, Bernhardt Sachs, Klaus Kraywinkel, Maike Schulz, Matthias Schmid, Wilma Fischer-Barth, and Jens Bate. 2023. “Analyses of Basal and Squamous Cell Carcinoma Reported as an Adverse Drug Reaction and Comparison with Cases from the Cancer Registry from Germany.” Drugs in R&D 23 (1): 21–33. doi:10.1007/s40268-022-00407-1.